ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 98 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,783,000 | -23.9% | 85,927 | +0.0% | 0.00% | -33.3% |
Q3 2016 | $2,342,000 | +77.3% | 85,913 | -6.4% | 0.00% | +50.0% |
Q2 2016 | $1,321,000 | +5.8% | 91,787 | +5.6% | 0.00% | 0.0% |
Q1 2016 | $1,249,000 | -20.6% | 86,946 | +18.8% | 0.00% | 0.0% |
Q4 2015 | $1,573,000 | +33.9% | 73,196 | +0.8% | 0.00% | 0.0% |
Q3 2015 | $1,175,000 | -38.0% | 72,635 | -1.0% | 0.00% | 0.0% |
Q2 2015 | $1,895,000 | +35.3% | 73,405 | +17.9% | 0.00% | 0.0% |
Q1 2015 | $1,401,000 | +18.4% | 62,271 | +1.0% | 0.00% | 0.0% |
Q4 2014 | $1,183,000 | -11.0% | 61,624 | -0.4% | 0.00% | 0.0% |
Q3 2014 | $1,329,000 | -17.4% | 61,891 | +0.0% | 0.00% | 0.0% |
Q2 2014 | $1,608,000 | +139.3% | 61,865 | +100.7% | 0.00% | +100.0% |
Q1 2014 | $672,000 | +81.1% | 30,829 | +1.5% | 0.00% | 0.0% |
Q4 2013 | $371,000 | -9.5% | 30,377 | -0.7% | 0.00% | 0.0% |
Q3 2013 | $410,000 | +91.6% | 30,602 | +16.2% | 0.00% | – |
Q2 2013 | $214,000 | – | 26,336 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 2,067,560 | $53,364,000 | 28.19% |
Selkirk Management LLC | 208,000 | $5,368,000 | 2.94% |
Iguana Healthcare Management, LLC | 270,000 | $6,969,000 | 2.20% |
Opaleye Management Inc. | 100,600 | $2,596,000 | 1.03% |
Miura Global Management | 600,000 | $15,486,000 | 0.94% |
DSC Advisors, L.P. | 57,400 | $1,481,000 | 0.77% |
Cannell & Co. | 1,016,828 | $26,244,000 | 0.74% |
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $7,138,000 | 0.61% |
Harvest Capital Strategies LLC | 100,000 | $2,581,000 | 0.33% |
Raging Capital Management, LLC | 93,932 | $2,424,000 | 0.31% |